Status: Phase 2
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Ischemia; Stroke Phase 1 ClinicalTrials
Myelodysplastic Syndromes Phase 2 ClinicalTrials
CONTENTS